Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain ...Middle East

GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4. FZ002-037 is a highly selective oral...

Read More Details
Finally We wish PressBee provided you with enough information of ( Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain )

Also on site :

• Fred Smith's 10 Children: All About the Pioneering Billionaire's Kidsc
• Netherlands returns 119 looted artifacts known as Benin Bronzes to Nigeria
• Moscow blasts US redo of ‘Iraqi weapons of mass destruction’ stunt